Pfizer’s Bioethics Advisory Panel is an external group of ethicists, clinical researchers, patient advocates and academics who provide Pfizer with independent, expert perspectives on globally complex issues at the crossroads of research, medicine and ethics. The panel’s guidance on emerging issues and scientific trends helps inform Pfizer’s R&D planning and policies, ensuring that the interests of the patient and the public remain core to our R&D activities. The panel addresses a range of topics, including conducting clinical research in vulnerable patient populations, ownership, use, privacy and security of patient data, compassionate access and gene therapies and our relationships with academic, research and patient communities.
.jpg)
Share this page
